As of 2026-04-02, the Intrinsic Value of Atea Pharmaceuticals Inc (AVIR) is -49.69 USD. This Atea valuation is based on the model Peter Lynch Fair Value. With the current market price of 5.65 USD, the upside of Atea Pharmaceuticals Inc is -979.45%.
Based on its market price of 5.65 USD and our intrinsic valuation, Atea Pharmaceuticals Inc (AVIR) is overvalued by 979.45%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -49.69 - -49.69 | -49.69 | -979.45% |
| P/E | (36.49) - (40.35) | (38.11) | -774.5% |
| DDM - Stable | (15.37) - (45.11) | (30.24) | -635.2% |
| DDM - Multi | (13.87) - (32.64) | (19.58) | -446.5% |
| Market Cap (mil) | 450.14 |
| Beta | 0.17 |
| Outstanding shares (mil) | 79.67 |
| Enterprise Value (mil) | 354.42 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.51% |
| Cost of Debt | 5.00% |
| WACC | 7.73% |